Overview Drug Interactions Between Silimarine and Darunavir/Ritonavir Status: Completed Trial end date: 2011-07-01 Target enrollment: Participant gender: Summary This is a clinical trial to characterize drug interactions between silimarine and the protease inhibitor darunavir/ritonavir. Phase: Phase 4 Details Lead Sponsor: Fundacio Lluita Contra la SIDAFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaCollaborators: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauIrsiCaixaTreatments: DarunavirRitonavir